Development, Optimization and In Vitro Characterization of Eudragit-Ganciclovir Nanosuspension or Treating Herpes Simplex Keratitis

Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Dev Ind Pharm. 2013;39(11):1599–617.

Article  CAS  Google Scholar 

Sultana Y, Jain R, Aqil M, Ali A. Review of ocular drug delivery. Curr Drug deliv. 2006;3(2):207–17.

Article  CAS  PubMed  Google Scholar 

Lynch C, Kondiah PPD, Choonara YE, du Toit LC, Ally N, Pillay V. Advances in Biodegradable Nano-Sized polymer-based ocular drug delivery. Polymers (Basel). 2019;11(8):1371. https://doi.org/10.3390/polym11081371. PMID:31434273; PMCID:PMC6722735.

Article  CAS  PubMed  Google Scholar 

Vandervoort J, Annick L. Ocular drug delivery: nanomedicine applications. 2007:11–21.

Singh S, Neelam SA, Singla YP. An overview of multifaceted significance of eudragit polymers in drug delivery systems. Asian J Pharm Clin Res. 2015;8(5):1–6.

Article  Google Scholar 

Pignatello R, Bucolo C, Puglisi G. Ocular tolerability of Eudragit RS100® and RL100® nanosuspensions as carriers for ophthalmic controlled drug delivery. J Pharm Sci. 2002;91(12):2636–41.

Article  CAS  PubMed  Google Scholar 

Taghe S, Mirzaeei S, Alany RG, Nokhodchi A. Polymeric inserts containing Eudragit® L100 nanoparticle for improved ocular delivery of azithromycin. Biomedicines. 2020;8(11):466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akhter S, Talegaonkar S, Khan ZI, Jain GK, Khar RK, Ahmad FJ. Assessment of ocular pharmacokinetics and safety of Ganciclovir loaded nanoformulations. J Biomed Nanotech. 2011;7(1):144–5.

Article  CAS  Google Scholar 

Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 1990;39(4):597–638.  https://doi.org/10.2165/00003495-199039040-00008. PMID: 2161731.

Kapanigowda UG, Nagaraja SH, Ramaiah B, Boggarapu PR. Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats. Daru. 2015;23:49. https://doi.org/10.1186/s40199-015-0132-7.PMID:26497653;PMCID:PMC4620023.

Article  PubMed  PubMed Central  Google Scholar 

Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis, Curr Eye Res. 2012;37:7654–660. https://doi.org/10.3109/02713683.2012.692846.

Kumar N, Aggarwal R, Chauhan MK. Extended levobunolol release from Eudragit nanoparticle-laden contact lenses for glaucoma therapy. Futur J Pharm Sci. 2020;6:109. https://doi.org/10.1186/s43094-020-00128-9.

Article  Google Scholar 

Maaz A, Abdelwahed W, Tekko IA, Trefi S. Influence of nanoprecipitation method parameters on nanoparticles loaded with gatifloxacin for ocular drug delivery. 2015.

Eid HM, Naguib IA, Alsantali RI, Alsalahat I, Hegazy AM. Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin. J Pharm Sci. 2021;110(8):3027–3036. ISSN 0022–3549. https://doi.org/10.1016/j.xphs.2021.04.020.

Pujitha C, Jyothi JS, Sucharitha J, Lakshmi GN, Rao AL. Formulation and characterization of ofloxacin opthalmic GEL.

Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.

Article  CAS  PubMed  Google Scholar 

Eid HM, Elkomy MH, El Menshawe SF, et al. Development, optimization, and in vitro/in vivo characterization of enhanced lipid nanoparticles for ocular delivery of ofloxacin: the influence of pegylation and chitosan coating. AAPS PharmSciTech. 2019;20:183. https://doi.org/10.1208/s12249-019-1371-6.

Article  CAS  PubMed  Google Scholar 

Dave V, Paliwal S. A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation. Saudi Pharm J. 2014;22(3):240–5. https://doi.org/10.1016/j.jsps.2013.03.001.

Article  PubMed  Google Scholar 

Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech. 2010;11(3):1250–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhamhoom Y, Ravi G, Osmani RAM, Hani U, Prakash GM. Formulation, characterization, and evaluation of eudragit-coated saxagliptin nanoparticles using 3 factorial design modules. Molecules. 2022;27(21):7510. https://doi.org/10.3390/molecules27217510. PMID:36364338; PMCID:PMC9653823.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma UK, Verma A, Prajapati SK, Pandey HS, Pandey AC. In vitro, in vivo and pharmacokinetic assessment of amikacin sulphate laden polymeric nanoparticles meant for controlled ocular drug delivery. Appl Nanosci. 2015;5:143–55.

Article  CAS  Google Scholar 

Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 2004;8:1428–39. https://doi.org/10.1023/b:pham.0000036917.75634.be. PMID: 15359578.

Article  Google Scholar 

Katara R, Sachdeva S, Majumdar DK. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery. Pharm Dev Technol. 2019;24(3):368–79.

Article  CAS  PubMed  Google Scholar 

Sakhare S, Shinde SD, Yadav AV, Shete AS. Studies on formulation and evaluation of Eudragit RS PO based nanoparticulate system of aceclofenac for ocular delivery. Indian J Pharm Educ Res. 2021;55(1):S87-99.

Article  CAS  Google Scholar 

Mohammadi G, Mirzaeei S, Taghe S, Mohammadi P. Preparation and evaluation of Eudragit® L100 nanoparticles loaded impregnated with KT tromethamine loaded PVA-HEC insertions for ophthalmic drug delivery. Adv Pharm Bull. 2019;9(4):593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verma P, Gupta RN, Jha AK, Pandey R. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide. Drug Deliv. 2013;20(7):269–76. https://doi.org/10.3109/10717544.2013.834417. PMID: 24044644.

Article  CAS  PubMed  Google Scholar 

Ahmed L, Atif R, Eldeen TS, Yahya I, Omara A, Eltayeb M. Study the using of nanoparticles as drug delivery system based on mathematical models for controlled release. Int J Eng Technol. 2019;8(5):52–6.

Google Scholar 

Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vis. 2003;9:559–68. PMID: 14566223.

CAS  PubMed  Google Scholar 

Morsi N, Ghorab D, Refai H, Teba H. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm. 2016;506(1–2):57–67. https://doi.org/10.1016/j.ijpharm.2016.04.021. PMID: 27091293.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif